You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 12, December 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS PRESENTED AT THE 44TH ANNUAL CANCER SYMPOSIUM OF THE SOCIETY OF SURGICAL ONCOLOGY
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Carbohydrate-Binding Protein 35 Is the Major Cell-Surface Laminin-Binding Protein in Colon Carcinoma

Edward C. Lee, MD; Hee-Jong Woo, DVM, PhD; Cynthia A. Korzelius; Glenn D. Steele, Jr, MD, PhD; Arthur M. Mercurio, PhD

Arch Surg. 1991;126(12):1498-1502.


Abstract

• The interaction of tumor cells with laminin is thought to be critical in invasion and metastasis. We found that an endogenous lectin, carbohydrate-binding protein 35 (CBP-35), is the major laminin-binding protein on human colon carcinoma cells and that its surface expression suggests involvement in metastasis. We identified CBP-35 by lamininaffinity chromatography and immunoblotting. Surface expression of CBP-35 on eight human colon carcinoma cell lines was compared by flow cytometry. Poorly differentiated cell lines and DLD-2, a signet-ring carcinoma cell line, expressed more surface CBP-35 than well-differentiated cell lines. Poorly differentiated cell lines and DLD-2 are characterized as aggressive cell lines because they adhere to and invade through reconstituted basement membrane significantly better than well-differentiated cell lines. These data suggest that CBP-35 is involved in tumor cell-basement membrane interactions and that an increase in CBP-35 surface expression may facilitate metastatic potential of colon carcinoma cells.

(Arch Surg. 1991;126:1498-1502)



Author Affiliations

From the Laboratory of Cancer Biology, Deaconess Hospital, Harvard Medical School, Boston, Mass.


Footnotes

Accepted for publication September 1, 1991.

Presented at the 44th Annual Cancer Symposium of the Society of Surgical Oncology, Orlando, Fla, March 26, 1991.

Reprint requests to Laboratory of Cancer Biology, Deaconess Hospital, Harvard Medical School, 50 Binney St, Boston, MA 02115 (Dr Mercurio).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Genetic assessment of the importance of galectin-3 in cancer initiation, progression, and dissemination in mice
Eude-Le Parco et al.
Glycobiology 2009;19:68-75.
ABSTRACT | FULL TEXT  

Galectin-3 Messenger Ribonucleic Acid and Protein Are Expressed in Benign Thyroid Tumors
Martins et al.
J. Clin. Endocrinol. Metab. 2002;87:4806-4810.
ABSTRACT | FULL TEXT  

Up-Regulation of Galectin-3 in Acute Renal Failure of the Rat
Nishiyama et al.
Am. J. Pathol. 2000;157:815-823.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.